Hardik Shah
2026.07.15 16:25

๐Ÿ“ข ๐‰๐”๐’๐“ ๐ˆ๐: EU Approves Novo Nordisk's Oral Wegovy for Obesity Treatment - $Novo Nordisk AS(NVO.US) $Hims & Hers Health(HIMS.US) $Eli Lilly(LLY.US)

๐Ÿ‘‰ ๐Š๐ž๐ฒ ๐‡๐ข๐ ๐ก๐ฅ๐ข๐ ๐ก๐ญ๐ฌ:

โžค ๐„๐ฎ๐ซ๐จ๐ฉ๐ž๐š๐ง ๐‚๐จ๐ฆ๐ฆ๐ข๐ฌ๐ฌ๐ข๐จ๐ง approves ๐จ๐ซ๐š๐ฅ ๐–๐ž๐ ๐จ๐ฏ๐ฒ ๐Ÿ๐Ÿ“ ๐ฆ๐ .

โžค Approval covers adults with ๐จ๐›๐ž๐ฌ๐ข๐ญ๐ฒ or overweight with comorbidities.

โžค Oral Wegovy becomes Novo Nordisk's ๐Ÿ๐ข๐Ÿ๐ญ๐ก regulatory approval globally.

โžค OASIS 4 trial showed approximately ๐’๐Ÿ•% mean weight loss over 64 weeks.

โžค Placebo group recorded approximately ๐’๐Ÿ‘% mean weight loss.

โžค Around ๐จ๐ง๐ž ๐ข๐ง ๐ญ๐ก๐ซ๐ž๐ž participants lost ๐’๐Ÿ๐ŸŽ% or more body weight.

โžค EU also approved ๐–๐ž๐ ๐จ๐ฏ๐ฒ ๐Ÿ•.๐Ÿ ๐ฆ๐  single-dose injection pen.

โžค Novo Nordisk says the injection delivers approximately ๐’๐Ÿ๐Ÿ% weight loss.

โžค Company plans additional global launches in ๐ญ๐ก๐ž ๐ฌ๐ž๐œ๐จ๐ง๐ ๐ก๐š๐ฅ๐Ÿ ๐จ๐Ÿ ๐Ÿ๐ŸŽ๐Ÿ๐Ÿ”.

๐Ÿ‘‰ ๐„๐ฑ๐ฉ๐ž๐ซ๐ญ ๐’๐ญ๐š๐ญ๐ž๐ฆ๐ž๐ง๐ญ:

๐Œ๐ข๐ค๐ž ๐ƒ๐จ๐ฎ๐ฌ๐ญ๐๐š๐ซ, president and CEO of Novo Nordisk:

"For many people, a tablet may be a simpler and more acceptable way to start and continue treatment."

The copyright of this article belongs to the original author/organization.

The views expressed herein are solely those of the author and do not reflect the stance of the platform. The content is intended for investment reference purposes only and shall not be considered as investment advice. Please contact us if you have any questions or suggestions regarding the content services provided by the platform.